“We have seen clients putting their U.S. IPO plans on hold for now,” said Stephen Chan, a partner at law firm Dechert LLP in Hong Kong. “The underlying reason for the slowdown is the relationship between the U.S. and China,” he added.
“If tensions between the two nations remain, we would expect the slowdown to continue,” Chan said.
Chinese groups have raised $1.67 billion via initial public offerings in New York this year and are looking to raise about half billion more on U.S. exchanges, Dealogic data shows.
In 2019, they raised $3.5 billion.
Sino-U.S. relations have nosedived in recent months with the countries, already at odds over trade, now butting heads over the COVID-19 pandemic and China’s proposed national security law for Hong Kong.
Enquiries about U.S. listings have halved this year at one of the big four accounting firms in China versus 2019 levels, a senior auditor from the firm said.
Many companies that reported plans for U.S. listings to China’s securities regulator, marking an early stage in the process, are now targeting exchanges nearer to home, said a person close to the regulator.
Listings take at the minimum several months to arrange, involving appointing advisers, preparing a prospectus and obtaining regulatory approvals. The further along the path a company is, the less likely it is to change plans.
‘INVESTOR UNCERTAINTY’
Chinese firms accounted for about a third, or some $279 billion, of funds raised globally via IPOs in the past five years. About half of that was overseas, mostly through New York and Hong Kong floats.There are more than 550 Chinese firms listed on U.S. stock exchanges. Chinese firms often choose New York for floats given its prestige and international investor base, even as Beijing seeks to encourage them to list at home to share gains among local investors and limit foreign oversight.
Chinese authorities have long resisted audit papers leaving China, making it hard for U.S. auditing regulators to check the quality of audits of Chinese companies.
But a bill passed by the U.S. Senate which, if signed by President Donald Trump, would require U.S.-listed foreign companies to disclose levels of government control. It would also require that Chinese companies comply with U.S. oversight of their audits or face being delisted.
“For U.S. investors, it will mean fewer listings and it will be harder to capture the benefits of growth in China,” said John Ott, partner with Bain & Company and a leader with its Greater China financial services practice.
U.S.-listed Chinese firms have begun disclosing the risk of an “adverse impact” on their shares due to tighter regulations.
Netease (NTES.O) and JD.com (JD.O) also warned of similar risks in their recent filings with the Hong Kong stock exchange for secondary listings in the city.
https://www.reuters.com/article/us-china-usa-ipo/chinese-companies-put-u-s-listing-plans-on-ice-as-tensions-mount-idUSKBN23H01U
